VOLT vs CCRN vs KELYA vs TBI

For growth investors, Volt Information Sciences, Inc.

(VOLT) is the stronger pick with 7. 7% revenue growth year-over-year, versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). Volt Information Sciences, Inc. (VOLT) offers the better valuation at 663. 2x trailing P/E, making it the more compelling value choice. Analysts rate Kelly Services, Inc. (KELYA) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Kelly Services, Inc.

is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Volt Information Sciences, Inc.

(VOLT) delivered a total return of +939. 9%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: VOLT returned +1164% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cross Country Healthcare, Inc.

(CCRN) is the lower-risk stock at 0. 78β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 46% more volatile than CCRN relative to the S&P 500. On balance sheet safety, Cross Country Healthcare, Inc. (CCRN) carries a lower debt/equity ratio of 1% versus 3% for Volt Information Sciences, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Volt Information Sciences, Inc.

(VOLT) is pulling ahead at 7. 7% versus -21. 6% for Cross Country Healthcare, Inc. (CCRN). On earnings-per-share growth, the picture is similar: Volt Information Sciences, Inc. grew EPS 103. 9% year-over-year, compared to -427. 4% for Kelly Services, Inc.. Over a 3-year CAGR, KELYA leads at -5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Volt Information Sciences, Inc.

(VOLT) is the more profitable company, earning 0. 2% net margin versus -9. 0% for Cross Country Healthcare, Inc. — meaning it keeps 0. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VOLT leads at 0. 5% versus -1. 7% for TBI. At the gross margin level — before operating expenses — TBI leads at 21. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Kelly Services, Inc.

(KELYA) trades at 11. 0x forward P/E versus 133. 8x for Cross Country Healthcare, Inc. — 122. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KELYA: 54. 6% to $15. 00.

In this comparison, KELYA (3.

2% yield) pays a dividend. VOLT, CCRN, TBI do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Volt Information Sciences, Inc.

(VOLT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1164% 10Y return). Both have compounded well over 10 years (VOLT: +1164%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (VOLT (Industrials) and CCRN (Healthcare) and KELYA (Industrials) and TBI (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VOLT is a small-cap quality compounder stock; CCRN is a small-cap quality compounder stock; KELYA is a small-cap income-oriented stock; TBI is a small-cap quality compounder stock. KELYA pays a dividend while VOLT, CCRN, TBI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.